Zeteo Tech

Zeteo Tech is a private, venture-backed company pioneering field-deployable biological mass spectrometry for dual-use applications in biodefense and public health diagnostics. Its core innovation is a miniaturized, low-cost digitalMALDI® platform, initially funded by the U.S. Department of Defense and the Bill & Melinda Gates Foundation, which detects bio-threats and pathogens from aerosol samples without reagents or culturing. The company has won prestigious awards like the Tibbetts Award and is advancing its technology through contracts with U.S. government agencies and NIH grants, positioning it at the intersection of national security and global health.

digitalMALDI® time-of-flight mass spectrometry for fieldable, reagent-free detection and identification of airborne biological particles (microbes, proteins, lipids) from environmental and breath samples.

Zeteo competes with large defense contractors offering traditional bio-detection systems and established diagnostic companies using PCR, immunoassays, or lab-based MALDI-TOF. Its primary differentiation is a fieldable, reagent-free platform offering lower operating costs and near real-time results, but it faces competition from other emerging detection technologies like CRISPR-based assays and advanced biosensors.